THE CRUNCH
The UK government has launched the AI Biosecurity Lab (AIBL), committing £100 million (about $134 million) as part of its National AI Biosecurity Initiative. The lab will operate as an independent, non-profit organisation and bring together biosecurity and life sciences experts to work with frontier AI on detecting biological threats and accelerating vaccines and medical treatments. It will also partner with public-sector bodies and academic institutions.
Several AI companies are backing the effort. OpenAI is providing £100 million in credits for access to its most advanced models and computing infrastructure, Anthropic is offering £100 million in model credits, and Google DeepMind's biosecurity experts will collaborate on research while supplying access to its frontier Gemini models. UK AI life sciences company Basecamp Research will contribute AI-biology models and biosecurity expertise.
The government framed the lab as a response to a double-edged technology. In its announcement it said AI systems are creating "unprecedented opportunities for scientific discovery" but also "new biological risks and could lower barriers to harmful activity." As an illustration of how frontier AI is already being used in biotech, the announcement pointed to a California research lab that recently claimed to have created a virus with AI and administered it to a human patient, in that case to infect antibiotic-resistant bacteria rather than for any harmful purpose.
Britain's AI minister Kanishka Narayan called the lab "a major new global institution, bringing together world-leading scientific expertise to protect people from emerging biological threats and ensure Britain leads the world in AI safety and security." The government said AIBL's research will strengthen UK and global resilience to a wide range of biological risks, "including those enabled by advances in AI."